Document is current
Any future updates will be listed below
-
Authors
Nakhoda, Shazia K.
Olszanski, Anthony J. https://orcid.org/0000-0001-5276-5898
- License Information
-
More Information
Article History
First Online: 10 March 2020
Compliance with Ethical Standards
:
: No sources of funding were used to conduct this study or prepare this manuscript.
: Shazia K. Nakhoda has no conflicts of interest that might be relevant to the contents of this manuscript. Anthony J. Olszanski sits on advisory boards, with commensurate honorarium, for Array, BMS, Merck, Novartis, and Pfizer. Additionally, the institution receives funding from trials for which he is participating, including from Adaptimmune, Astellas, BMS, Boston Biomedical, Checkmate Pharmaceutical, EMD Serono, GlycoNex, Immoncore, Incyte, Intensity Therapeutics, Kadmon, Kartos, Kura, Nektar, NGM Biopharmaceutical, Oncoceutics, OncoSec, Seattle Genetics, Sound Biologics, Spring Bank, Takeda, and Targovax.
